Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum]

Jones G, Panova E, Day R. Drug Des Devel Ther. 2017;11:3077-3081.On page 3078, Table 1, Abbreviation list, expansion for FBX was incorrectly listed as feboxustat, the correct spelling is febuxostat.Read the original article

Saved in:
Bibliographic Details
Published in:Drug design, development and therapy development and therapy, 2017-01, Vol.11, p.3589-3590
Main Authors: Jones, Graeme, Panova, Elena, Day, Richard
Format: Article
Language:English
Subjects:
Corrigendum
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Jones G, Panova E, Day R. Drug Des Devel Ther. 2017;11:3077-3081.On page 3078, Table 1, Abbreviation list, expansion for FBX was incorrectly listed as feboxustat, the correct spelling is febuxostat.Read the original article
ISSN:1177-8881
1177-8881
DOI:10.2147/DDDT.S158965